Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Chiara Di Bartolo"'
Autor:
Salvatore Pasqua, Maria Concetta Niotta, Giuseppina Di Martino, Davide Sottile, Bruno Douradinha, Monica Miele, Francesca Timoneri, Mariangela Di Bella, Nicola Cuscino, Chiara Di Bartolo, Pier Giulio Conaldi, Danilo D’Apolito
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss , Pp 320-329 (2021)
Endotoxin content is a critical factor that affects the safety of biological pharmaceutical products. International pharmacopoeias describe several reference methods to determine endotoxin levels in advanced therapy medicinal product (ATMP) preparati
Externí odkaz:
https://doaj.org/article/003d1bb7774b440285018e95821eda62
Autor:
Salvatore Pasqua, Giampiero Vitale, Anna Pasquariello, Bruno Douradinha, Fabio Tuzzolino, Francesca Cardinale, Chiara Cusimano, Chiara Di Bartolo, Pier Giulio Conaldi, Danilo D’Apolito
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss , Pp 542-550 (2021)
Effective detection of microbiological contaminations present in medicinal cellular products is a crucial step to ensure patients’ safety. In recent decades, several rapid microbiological methods have been developed and validated, but variabilities
Externí odkaz:
https://doaj.org/article/e6525273e3c64f6c8fdf67effe813ae2
Autor:
Francesca Timoneri, Maria Concetta Niotta, Davide Sottile, Mariangela Di Bella, Bruno Douradinha, Chiara Di Bartolo, Giuseppina Di Martino, Danilo D'Apolito, Salvatore Pasqua, Monica Miele, Pier Giulio Conaldi, Nicola Cuscino
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 22, Iss, Pp 320-329 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 567-568 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy: Methods & Clinical Development, Vol 23, Iss, Pp 567-568 (2021)
Endotoxin content is a critical factor that affects the safety of biological pharmaceutical products. International pharmacopoeias describe several reference methods to determine endotoxin levels in advanced therapy medicinal product (ATMP) preparati
Autor:
Bruno Douradinha, Salvatore Pasqua, Fabio Tuzzolino, Pier Giulio Conaldi, Chiara Di Bartolo, Giampiero Vitale, Danilo D'Apolito, Francesca Cardinale, Anna Pasquariello, Chiara Cusimano
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 20, Iss, Pp 542-550 (2021)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Effective detection of microbiological contaminations present in medicinal cellular products is a crucial step to ensure patients’ safety. In recent decades, several rapid microbiological methods have been developed and validated, but variabilities
Autor:
Pier Giulio Conaldi, Lucia D'Aiello, Bruno Douradinha, Giuseppina Di Martino, Danilo D'Apolito, Chiara Di Bartolo, Lucia Pecoraro, Salvatore Pasqua, Floriana Barbera
Publikováno v:
Biologicals. 64:49-57
Advanced therapy medicinal products (ATMP) are required to maintain their quality and safety throughout the production cycle, and they must be free of microbial contaminations. Among them, mycoplasma contaminations are difficult to detect and undesir
Autor:
Chiara Di Bartolo, Francesco Monaco, Bruno Douradinha, Giuseppina Di Martino, Danilo D'Apolito, Salvatore Pasqua, Pier Giulio Conaldi
Publikováno v:
International Journal of Environmental Research and Public Health
International Journal of Environmental Research and Public Health, Vol 18, Iss 779, p 779 (2021)
Volume 18
Issue 2
International Journal of Environmental Research and Public Health, Vol 18, Iss 779, p 779 (2021)
Volume 18
Issue 2
To evaluate and validate the efficacy of disinfectants used in our cleaning procedure, in order to reduce pharmaceutical hospital surfaces&rsquo
contaminations, we tested the action of three commercial disinfectants on small representative sampl
contaminations, we tested the action of three commercial disinfectants on small representative sampl
Autor:
Jörg C. Gerlach, Fabio Lopez, A. Passannanti, Fabio Triolo, Chiara Di Bartolo, Bruno Gridelli, Tommaso Piazza
Publikováno v:
Risk Analysis. 30:1857-1871
International regulatory authorities view risk management as an essential production need for the development of innovative, somatic cell-based therapies in regenerative medicine. The available risk management guidelines, however, provide little guid
Publikováno v:
Plastic and Reconstructive Surgery. 118:341-346
Background Facial aging results from reduced biosynthetic activity of dermal fibroblasts and decreased deposition of extracellular matrix components, such as hyaluronic acid, a glycosaminoglycan responsible for skin hydration and turgidity. Exogenous
Autor:
Assunta Borzacchiello, Laura Mayol, Andrea Pastorello, Luigi Ambrosio, Piera A. Ramires, E. Milella, Chiara Di Bartolo
Publikováno v:
Biomaterials 28 (2007): 4399–4408. doi:10.1016/j.biomaterials.2007.06.007
info:cnr-pdr/source/autori:A. Borzacchiello; L. Mayol; P.A. Ramires; C. Di Bartolo; A. Pastorello; L. Ambrosio; E. Milella/titolo:Structural and rheological characterization of hyaluronic acid-based scaffolds for adipose tissue engineering/doi:10.1016%2Fj.biomaterials.2007.06.007/rivista:Biomaterials/anno:2007/pagina_da:4399/pagina_a:4408/intervallo_pagine:4399–4408/volume:28
info:cnr-pdr/source/autori:A. Borzacchiello; L. Mayol; P.A. Ramires; C. Di Bartolo; A. Pastorello; L. Ambrosio; E. Milella/titolo:Structural and rheological characterization of hyaluronic acid-based scaffolds for adipose tissue engineering/doi:10.1016%2Fj.biomaterials.2007.06.007/rivista:Biomaterials/anno:2007/pagina_da:4399/pagina_a:4408/intervallo_pagine:4399–4408/volume:28
In this study the attention has been focused on the ester derivative of hyaluronic acid (HA), HYAFF ® 11, as a potential three-dimensional scaffold in adipose tissue engineering. Different HYAFF ® 11 sponges having different pore sizes, coated or n
Autor:
Fabio, Lopez, Chiara, Di Bartolo, Tommaso, Piazza, Antonino, Passannanti, Jörg C, Gerlach, Bruno, Gridelli, Fabio, Triolo
Publikováno v:
Risk analysis : an official publication of the Society for Risk Analysis. 30(12)
International regulatory authorities view risk management as an essential production need for the development of innovative, somatic cell-based therapies in regenerative medicine. The available risk management guidelines, however, provide little guid